Evidence map›Paper›PMID 35093590›Full record

ArticleCellular and molecular gastroenterology and hepatology2022

Regulation of Liver Regeneration by Hepatocyte O-GlcNAcylation in Mice.

Dakota R Robarts, Steven R McGreal, David S Umbaugh, Wendena S Parkes, Manasi Kotulkar, Sarah Abernathy, Norman Lee, Hartmut Jaeschke, Sumedha Gunewardena, Stephen A Whelan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Regulation of hepatic xenosensor function by HNF4alpha.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  6. Review
  7. Article
  8. JHEP reports : innovation in hepatology · 2024
    Article
  9. Article
  10. HNF4α in Hepatocyte Health and Disease.Seminars in liver disease · 2023
    Review
  11. Review
  12. Effect of PdInternational journal of molecular sciences · 2022
    Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Dakota R RobartsDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Steven R McGrealDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
David S UmbaughDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Wendena S ParkesDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Manasi KotulkarDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Sarah AbernathyDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Norman LeeDepartment of Chemistry, Boston University, Boston, Massachusetts.
Hartmut JaeschkeDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas.
Sumedha GunewardenaDepartment of Molecular and Integrative Physiology, Kansas City, Kansas.
Stephen A WhelanDepartment of Chemistry, Boston University, Boston, Massachusetts.
John A HanoverLaboratory of Cell Biochemistry and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Natasha E ZacharaDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chad SlawsonDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas.
Udayan ApteDepartment of Pharmacology, Toxicology and Therapeutics, Kansas City, Kansas. Electronic address: uapte@kumc.edu.
Boston University · USUniversity of Kansas Medical Center · USJohns Hopkins University · USNational Institutes of Health · US

Funding

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of DiseaseZIADK060101 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$25.7M
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegenerationZIADK060103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$20.8M
THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLASSEN, CURTIS D · 2006 to 2011
$12.1M
Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Pilot Grants ProgramP30GM118247 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2016 to 2020
$5.5M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
O-GLCNAC HOMEOSTASIS REGULATES MITOCHONDRIAL FUNCTION IN ALZHEIMER'S DISEASER01AG064227 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SLAWSON, CHAD ERIC · 2020 to 2024
$3.2M
Mechanisms of Liver Regeneration After Acetaminophen-Induced Acute Liver FailureR01DK098414 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI APTE, UDAYAN · 2013 to 2023
$3.0M
High Throughput Sequencing System for KUMC Genomics CoreS10OD021743 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SMITH, PETER G · 2017 to 2017
$493k
Role of HNF4alpha in Liver RegenerationR56DK112768 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI APTE, UDAYAN · 2018 to 2018
$364k
NCRR NIH HHS P20 RR021940NIA NIH HHS R01 AG064227NIDDK NIH HHS R01 DK098414NIDDK NIH HHS R56 DK112768NIEHS NIH HHS T32 ES007079NIGMS NIH HHS P30 GM118247
6 · The paper itself

Abstract

BACKGROUND &

aimsThe liver has a unique capacity to regenerate after injury in a highly orchestrated and regulated manner. Here, we report that O-GlcNAcylation, an intracellular post-translational modification regulated by 2 enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), is a critical termination signal for liver regeneration following partial hepatectomy (PHX).

methodsWe studied liver regeneration after PHX on hepatocyte specific OGT and OGA knockout mice (OGT-KO and OGA-KO), which caused a significant decrease (OGT-KO) and increase (OGA-KO) in hepatic O-GlcNAcylation, respectively.

resultsOGA-KO mice had normal regeneration, but the OGT-KO mice exhibited substantial defects in termination of liver regeneration with increased liver injury, sustained cell proliferation resulting in significant hepatomegaly, hepatic dysplasia, and appearance of small nodules at 28 days after PHX. This was accompanied by a sustained increase in expression of cyclins along with significant induction in pro-inflammatory and pro-fibrotic gene expression in the OGT-KO livers. RNA-sequencing studies revealed inactivation of hepatocyte nuclear 4 alpha (HNF4α), the master regulator of hepatic differentiation and a known termination signal, in OGT-KO mice at 28 days after PHX, which was confirmed by both Western blot and immunohistochemistry analysis. Furthermore, a significant decrease in HNFα target genes was observed in OGT-KO mice, indicating a lack of hepatocyte differentiation following decreased hepatic O-GlcNAcylation. Immunoprecipitation experiments revealed HNF4α is O-GlcNAcylated in normal differentiated hepatocytes.

conclusionsThese studies show that O-GlcNAcylation plays a critical role in the termination of liver regeneration via regulation of HNF4α in hepatocytes.

Indexed as

HepatocytesLiver RegenerationAnimalsHepatectomyLiverMiceMice, KnockoutCell DeathHNF4alphaPartial HepatectomyProliferationRegeneration

Identifiers

PMID35093590
PMCPMC9043307
OpenAlexW4226064803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.